Bohdan Chopko, MD, PhD

Clinical Associate Professor of Neurosurgery, Stanford Medicine;
Co-Founder, Silver Bullet
“Antimicrobial-coated implantable medical devices are likely to be the next big thing in the surgical suite. A technology that is designed to enhance patient safety while simultaneously helping to control costsis obviously a big step forward.”

Product Pipeline

​Amir Matityahu , MD

Professor of Orthopaedic Surgery, University of California, San Francisco
“The OrthoFuzIon Bone Screw System is a revolutionary device that kills bacteria locally. This is a problem that has not been solved with previously available implants. The well-proven safety of silver and platinum in low doses will allow the OrthoFuzIon System to be adopted rapidly and may lead to covering other surgical implants with the AntiBacterIon coating. Every day I have a patient at risk, I wish I had this implant.”​

The initial application of our proprietary coating is the OrthoFuzIon™ Antimicrobial Bone Screw System. In addition, other products may include dental implants, defibrillators/pacemakers and neurostimulator envelopes, sutures, venous catheters and mesh applications.

What the Experts Are Saying about the Disruptive Antimicrobial Technology Platform,

 from Silver Bullet Therapeutics 

John D. Barr, MD

rofessor of Radiology and Neurological Surgery, UT Southwestern Medical Center; Board of Directors, Silver Bullet
“The incidence of resistant medical device-related infections is climbing. Certainly, the prevention of device failures from device-related infections would benefit patients as well as the entire healthcare system.”